Evidence map›Paper›PMID 42276999›Full record

ArticleNature communications2026

Benchmarking large language models for cell-free RNA diagnostic biomarker discovery.

Hunter A Gaudio, Andrew Bliss, Conor J Loy, Daniel Eweis-LaBolle, Anne E Gardella, Iwijn De Vlaminck

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hunter A Gaudio *Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY, USA.ORCID http://orcid.org/0000-0002-3104-8467
Andrew Bliss *Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY, USA.ORCID http://orcid.org/0009-0008-1811-3878
Conor J LoyMeinig School of Biomedical Engineering, Cornell University, Ithaca, NY, USA.
Daniel Eweis-LaBolleMeinig School of Biomedical Engineering, Cornell University, Ithaca, NY, USA.ORCID http://orcid.org/0000-0001-7599-6082
Anne E GardellaMeinig School of Biomedical Engineering, Cornell University, Ithaca, NY, USA.ORCID http://orcid.org/0000-0003-1860-8316
Iwijn De VlaminckMeinig School of Biomedical Engineering, Cornell University, Ithaca, NY, USA. vlaminck@cornell.edu.ORCID http://orcid.org/0000-0001-6085-7311

Funding

Epigenetic Profiling of circulating cell-free DNA for the Monitoring of Graft-Versus-Host Disease after Hematopoietic Cell TransplantationR01AI146165 · NIAID · CORNELL UNIVERSITY · PI DE VLAMINCK, IWIJN, RITZ, JEROME · 2020 to 2024
$3.4M
Metagenomic profiling of urinary cell-free DNA to monitor urinary tract infection after kidney transplantationR01AI151059 · NIAID · CORNELL UNIVERSITY · PI DADHANIA, DARSHANA, DE VLAMINCK, IWIJN · 2020 to 2024
$3.4M
Diagnosis of tuberculosis and monitoring of treatment via RNA liquid biopsyR01AI192977 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Adithya Cattamanchi, Iwijn De Vlaminck · 2025 to 2026
$1.5M
Cell-free DNA as a versatile analyte for the monitoring of sepsisR21AI173979 · NIAID · CORNELL UNIVERSITY · PI DE VLAMINCK, IWIJN, SCHENCK, EDWARD JAMES · 2023 to 2024
$447k
NIAID NIH HHS R01 AI146165NIAID NIH HHS R01 AI151059NIAID NIH HHS R01 AI192977NIAID NIH HHS R21 AI173979U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01AI146165U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01AI151059U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01AI192977U.S. Department of Health & Human Services | National Institutes of Health (NIH) R21AI173979
6 · The paper itself

Abstract

Large language models can synthesize biomedical knowledge, parse vast amounts of data, and generate code, positioning them as promising tools for biomarker discovery from high-throughput omics data. Here, we benchmark six models from OpenAI, Anthropic, and Google on plasma cell-free RNA datasets spanning three clinical cohorts: Kawasaki disease versus multisystem inflammatory syndrome in children, active tuberculosis versus symptomatic respiratory controls, and myalgic encephalomyelitis/chronic fatigue syndrome versus sedentary controls. We evaluate literature-guided nomination of diagnostic gene panels for downstream machine learning and autonomous construction of end-to-end classifiers from raw count matrices to held-out test predictions. Despite prompt adherence issues, model-nominated panels recapitulate canonical immune pathways and outperform random panels across cohorts, even matching differential gene expression baselines in the tuberculosis cohort. End-to-end automation proves feasible but is model- and task-dependent. One model approaches conventional performance for Kawasaki disease versus multisystem inflammatory syndrome in children, whereas performance decreases for tuberculosis and myalgic encephalomyelitis/chronic fatigue syndrome cohorts. These findings delineate current capabilities and limitations of large language models in diagnostics and open a path for their future use in biomarker discovery.

Indexed as

BiomarkersCell-Free Nucleic AcidsLarge Language ModelsBenchmarkingChildHumansMucocutaneous Lymph Node SyndromeTuberculosisBiomarkersCell-Free Nucleic Acids

Identifiers

PMID42276999
PMCPMC13408832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.